Blog
Prodware: Current Operating Income sees strong upturn: 29.3 M€ (+103%) Operating Margin: 15.6%
Prodware: Current Operating Income sees strong upturn: 29.3 M€ (+103%) Operating Margin: 15.6%
TCS Group Holding PLC reports IFRS results for 4Q and FY 2022
TCS Group Holding PLC reports IFRS results for 4Q and FY 2022
Aroundtown SA notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities
Aroundtown SA notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities
EQS-Adhoc: KATEK SE: KATEK SE: KATEK SE Group wins new major customer in the eMobility sector
EQS-Adhoc: KATEK SE: KATEK SE: KATEK SE Group wins new major customer in the eMobility sector
Turkiye Garanti Bankasi A.S.: Disclosure regarding Sustainability Principles Compliance Framework
Turkiye Garanti Bankasi A.S.: Disclosure regarding Sustainability Principles Compliance Framework
Turkiye Garanti Bankasi A.S.: Regarding the Annual Report State of Responsibility
Turkiye Garanti Bankasi A.S.: Regarding the Annual Report State of Responsibility
EQS-Adhoc: Aumann AG: Aumann AG resolves share buyback program 2023
EQS-Adhoc: Aumann AG: Aumann AG resolves share buyback program 2023
Turkiye Garanti Bankasi A.S.: Garanti Bank 2022 Integrated Annual Report
Turkiye Garanti Bankasi A.S.: Garanti Bank 2022 Integrated Annual Report
EQS-News: Matthias Bäumer new member of the Supervisory Board
EQS-News: Matthias Bäumer new member of the Supervisory Board
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Hardman & Co Research on H&T (initiation of coverage): Pawnbroking royalty, with strong, profitable growth
Hardman & Co Research on H&T (initiation of coverage): Pawnbroking royalty, with strong, profitable growth
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
EQS-Adhoc: Einhell Germany AG: Peliminary business figures for 2022
EQS-Adhoc: Einhell Germany AG: Peliminary business figures for 2022
Rights and Issues Investment Trust PLC: Sub-Division of Ordinary Shares
Rights and Issues Investment Trust PLC: Sub-Division of Ordinary Shares
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
EQS-News: Vossloh Aktiengesellschaft: Executive Board contracts of Dr. Thomas Triska and Jan Furnivall extended
EQS-News: Vossloh Aktiengesellschaft: Executive Board contracts of Dr. Thomas Triska and Jan Furnivall extended
EQS-Adhoc: GN Store Nord A/S: Update on the agenda for GN Store Nord’s Annual General Meeting and capital raise
EQS-Adhoc: GN Store Nord A/S: Update on the agenda for GN Store Nord’s Annual General Meeting and capital raise
Media Release: Great performance, low price and attractive delivery time: the SFC6000 mass flow controller is available worldwide
Media Release: Great performance, low price and attractive delivery time: the SFC6000 mass flow controller is available worldwide